SlideShare a Scribd company logo
Public Health 101 Series
Instructor name
Title
Organization
Introduction to Public Health
Surveillance
Center for Surveillance, Epidemiology, and Laboratory Services
Division of Scientific Education and Professional Development
Note: This slide set is in the public domain and may be customized as needed by the
user for informational or educational purposes. Permission from the Centers for
Disease Control and Prevention is not required, but citation of the source is
appreciated.
Course Topics
2
Introduction to Public Health
Surveillance
1. A Public Health Approach
2. What is Public Health Surveillance?
3. Public Health Surveillance Role and Uses
4. Public Health Surveillance Legal Basis
5. Public Health Surveillance Types and
Attributes
6. Public Health Surveillance Process
By the end of this session, you will be able to
• define public health surveillance
• describe the goal of public health surveillance
• describe the uses of a public health surveillance system
• recognize the legal basis for public health surveillance in
the United States
• compare active and passive public health surveillance
• identify sources of data commonly used for public health
surveillance
• describe the public health surveillance process
Learning Objectives
3
A Public Health Approach
Topic 1
4
A Public Health Approach
Surveillance
Risk Factor
Identification
Intervention
Evaluation
Implementation
5
Public Health Core Sciences
6
Topic 2
What is Public Health
Surveillance?
7
The ongoing, systematic collection,
analysis, and interpretation of
health-related data essential to
planning, implementation, and
evaluation of public health practice,
closely integrated with the timely
dissemination of these data to those
responsible for prevention and
control
Public Health Surveillance Defined
Adapted from: Thacker SB, Birkhead GS. Surveillance. In: Gregg, MB, ed. Field epidemiology. Oxford, England: Oxford University Press;
2008. 8
analysis
interpretation
collection
dissemination
ongoing
systematic
health-related data
linked to public health practice
Public Health Surveillance Keywords
9
Goal of Public Health Surveillance
Provide information that can be used for health
action by public health personnel, government
leaders, and the public to guide public health
policy and programs
Smith PF, Hadler JL, Stanbury M, et al. Blueprint version 2.0: updating public health surveillance for the 21st century. J Public Health
Manag Pract 2013;19:231–9. 10
A. systemic, short-term
B. ongoing, systemic
C. ongoing, systematic
D. methodical, ongoing
Public Health Surveillance is the ________, __________
collection, analysis, and interpretation of health-
related data.
Knowledge Check
11
What is the goal of public health surveillance?
Knowledge Check
12
A. To give public health personnel policies to regulate
B. To provide information to be used for public
health action
C. To guide Congress in enacting public health laws
D. To keep the public aware of new diseases
Topic 3
Public Health Surveillance
Role and Uses
13
• Identify patients and their contacts for treatment and
intervention
• Detect epidemics, health problems, changes in health
behaviors
• Estimate magnitude and scope of health problems
• Measure trends and characterize disease
• Monitor changes in infectious and environmental agents
• Assess effectiveness of programs and control measures
• Develop hypotheses and stimulate research
Uses of Public Health Surveillance
14
Whooping Cough Kills Five in California;
State Declares an Epidemic
Number of Rare E. Coli Cases
In U.S. Rose Last Year
Increase Seen in Deaths from
Pneumonia and Flu
Percentage of New Yorkers Lighting Up
is Down to 14%
New CDC Report Shows Adult Obesity
Growing or Holding Steady in All States
15
Public Health Headlines
Number of Rare E. Coli Cases
In U.S. Rose Last Year
16
Neuman W. Number of Rare E. Coli Cases In U.S. Rose Last Year. The New York Times. June 7, 2011. http://www.nytimes.com.
Accessed July 8, 2014.
Identify the surveillance uses that can be linked to
the New York Times E. coli article.
A. Measure trends of a particular disease
B. Estimate the magnitude of the problem
C. Monitor changes in infectious and environmental
agents
D. Assess effectiveness of programs and control
measures
E. All of the above
Knowledge Check
17
Topic 4
Public Health Surveillance
Legal Basis
18
States have authority based on
the U.S. Constitution
• General welfare clause
• Interstate commerce clause
CDC responds when
• disease or condition has interstate
implications
• invited by a state
Legal Authority for Conducting
Public Health Surveillance
19
State-Based Notifiable Disease
Surveillance Systems
• Mandated by state law or regulation
• Health care providers, hospitals, and laboratories are
required to report cases to the local health
department (LHD)
• The LHD is usually responsible for case investigation
and action
• The LHD forwards the disease report to the state
health department
• The state health department assists the LHD as
needed
20
The purpose and legal basis for public health
surveillance is granted by which U.S. document?
A. Bill of Rights
B. Declaration of Independence
C. U.S. Constitution
D. 1812 Treaty of Public Health
Knowledge Check
21
CDC must be invited by a state before conducting
public health surveillance.
A. True
B. False
Knowledge Check
22
Topic 5
Public Health Surveillance
Types and Attributes
23
Passive Surveillance Active Surveillance
• Diseases are reported
by health care providers
• Simple and inexpensive
• Limited by incompleteness
of reporting and variability
of quality
• Health agencies contact
health providers seeking
reports
• Ensures more complete
reporting of conditions
• Used in conjunction
with specific epidemiologic
investigation
Types of Public Health Surveillance
24
Reporting of health events by health professionals who
are selected to represent a geographic area or a
specific reporting group
Can be active or passive
Sentinel Surveillance
Focuses on one or more symptoms rather than a
physician-diagnosed or laboratory-confirmed disease
Syndromic Surveillance
Other Types of Public Health Surveillance
25
Surveillance System Attributes
26
Attribute Question It Answers
Usefulness
How useful is the system in
accomplishing its objectives?
Data quality
How reliable are the available data?
How complete and accurate are data
fields in the reports received by the
system?
Timeliness How quickly are reports received?
Flexibility
How quickly can the system adapt to
changes?
Simplicity How easy is the system’s operation?
Surveillance System Attributes
27
Attribute Question It Answers
Stability
Does the surveillance system work
well?
Does it break down often?
Sensitivity
How well does it capture the
intended cases?
Predictive value
positive
How many of the reported cases
meet the case definition?
Representativeness
How good is the system at
representing the population under
surveillance?
Acceptability How easy is the system’s operation?
Knowledge Check
The New York State Department of Health contacts
the health providers in District A every Friday to obtain
the number of patients examined with Influenza. What
type of surveillance is this?
A. Passive
B. Active
28
Topic 6
29
Public Health Surveillance
Process
Before collecting data, decide
on the overarching goal
of the system
Surveillance Process
Data
Collection
Data Analysis
Data
Interpretation
Data
Dissemination
Link to Action
30
Data Sources for Public Health Surveillance
• Reported diseases or syndromes
• Electronic health records (e.g., hospital discharge
data)
• Vital records (e.g., birth and death certificates)
• Registries (e.g., cancer, immunization)
• Surveys (e.g., National Health and Nutrition
Examination Survey [NHANES])
31
Nationally Notifiable Disease
Surveillance System (NNDSS)
Many diseases on a state
list are also nationally
notifiable
32
Reporting to WHO is required for cases of
Internationally Notifiable Diseases
33
• Smallpox
• Poliomyelitis (wild type)
• Human influenza caused by
any new subtype
• Severe acute respiratory
syndrome (SARS)
• Who will analyze the data?
• What methodology will they
use?
• How often will they analyze
the data?
Surveillance Data Analysis
Data
Collection
Data Analysis
Data
Interpretation
Data
Dissemination
Link to Action
34
Patients Hospitalized with West Nile
Virus Infection, by Week, New York, 1999
Week of illness onset
Nash D, Mostashari F, Fine A, et al. Outbreak of West Nile virus infection in the New York City area in 1999.
N Engl J Med. 2001;344:1807–14. 35
North Queens
Serosurvey Area
Surveillance Data Analysis by Place
Laboratory-Confirmed WNV Human Cases — August–September 1999
Map Courtesy of the New York City Department of Health and Mental Hygiene
36
Characteristic No. of Patients (%) Population at Risk
Rate of Infection per
Million Population
Age (years)
0–19 2 (3) 2,324,081 0.9
20–29 1 (2) 1,553,981 0.6
30–39 3 (5) 1,549,111 1.9
40–49 1 (2) 1,177,190 0.8
50–59 9 (15) 867,331 10.4
60–69 12 (22) 814,838 16.0
70–79 18 (31) 534,785 33.7
≥80 12 (20) 281,054 42.7
Age category (years)
≥50 52 (88) 2,498,008 20.8
<50 7 (12) 6,604,363 1.1
Sex
Male 31 (53) 4,289,988 7.2
Female 28 (47) 4,812,383 5.8
Race
White 41 (69) 5,983,901 6.9
Nonwhite 9 (15) 3,118,470 2.9
Unknown 9 (15) -- --
Borough or county of residence
New York City
Brooklyn (Kings) 3 (5) 2,300,664 1.3
Bronx 9 (15) 1,203,789 7.5
Manhattan 1 (2) 1,487,536 0.7
Queens 32 (54) 1,951,599 16.4
Staten Island (Richmond) 0 379,999 0.0
New York State
Nassau 6 (10) 1,287,348 4.7
Westchester 8 (14) 847,866 9.1
Data Analysis by Person
Do you notice any patterns in the rates?
37Nash D, Mostashari F, Fine A, et al. Outbreak of West Nile virus infection in the New York City area in 1999. N Engl
J Med. 2001;344:1807–14.
Demographics for Persons Hospitalized for WNV and Population Rates of Infection
Data interpretation
is closely coupled
with data analysis
Surveillance Data Interpretation
Data
Collection
Data Analysis
Data
Interpretation
Data
Dissemination
Link to Action
38
What Can Account for an
Apparent Increase in Cases?Number of Rare E. Coli Cases
In U.S. Rose Last Year
39
Neuman, W. Rare E. Coli Cases Rose In the U.S. Last Year. New York Times June 7, 2011. http://www.nytimes.com. Accessed
July 9, 2014.
• Health agency newsletters,
bulletins, or alerts
• Surveillance summaries and
reports
• Medical and epidemiologic
journal articles
• Press releases and social
media
Data Dissemination
Data
Collection
Data Analysis
Data
Interpretation
Data
Dissemination
Link to Action
40
• Public health practitioners
• Clinicians and other health care providers
• Policy and other decision makers
• Community organizations
• The general public
Data Dissemination Target Audiences
41
Public health surveillance
should always have a
link to action
Surveillance Link to Action
Data
Collection
Data Analysis
Data
Interpretation
Data
Dissemination
Link to Action
42
Link to Action
Monitor trends and patterns in disease, risk factors, and agents
43
Source: Centers for Disease Control and Prevention (CDC). National Notifiable Diseases Surveillance System and Supplemental
Pertussis Surveillance System and 1922-1949, passive reports to the US Public Health Service. Atlanta, GA: US Department of
Health and Human Services, CDC. Available at: http://www.cdc.gov/pertussis/images/incidence-graph.jpg.
Pertussis (Whooping Cough) Cases, by Year — United States, 1922–2000
Choose the option that is NOT a part of the public
health surveillance process.
A. Data dissemination
B. Data storage
C. Link to action
D. Data collection
Knowledge Check
44
In data interpretation, by identifying the ___________,
________, and _____________, you can more easily
determine how and why the health event occurred.
A. disease, risk, occurrence
B. person, protocol, risk
C. person, place, time
D. risk, protocol, disease
Knowledge Check
45
Choose the option that is NOT a source of data used
for public health surveillance.
A. Administrative data systems
B. Vital records
C. Newspaper articles
D. Disease notifications
Knowledge Check
46
• Describe the burden of or potential for disease
• Monitor trends and patterns in disease, risk factors, and
agents
• Detect sudden changes in disease occurrence and
distribution
• Provide data for programs, policies, and priorities
• Evaluate prevention and control efforts
Public Health Surveillance-Based Action
47
Foege WH, Hogan RC, Newton LH. Surveillance projects for selected diseases. Int J Epidemiol 1976;5:29–37. 48
Photo: Kay Hinton, Emory University
“The reason for collecting,
analyzing, and disseminating
information on a disease is to
control that disease. Collection
and analysis should not be
allowed to consume resources if
action does not follow.”
—William Foege, 1976
During this session, you learned to
• define public health surveillance
• describe the goal of public health surveillance
• describe the uses of public health surveillance system
• recognize the legal basis for public health surveillance
in the United States
• compare active and passive public health surveillance
• identify sources of data commonly used for public health
surveillance
• describe the public health surveillance process
Course Summary
49
QUESTIONS?
50
• Smith PF, Hadler JL, Stanbury M, et al. Blueprint version 2.0: updating public
health surveillance for the 21st century. J Public Health Manag Pract
2013;19:231–9.
• Centers for Disease Control and Prevention. CDC’s vision for public health
surveillance in the 21st century. Morb Mortal Wkly Rep 2012;61(Suppl, July 27,
2012):1–40.
• Centers for Disease Control and Prevention (CDC). Principles of epidemiology
in public health practice [Self-Study Course]. 3rd ed. Atlanta, GA: US
Department of Health and Human Services, CDC; 2006.
http://www.cdc.gov/osels/scientific_edu/ss1978/SS1978.pdf.
• Lee LM, Teutsch SM, Thacker SB, St. Louis M, Eds. Principles and practice of
public health surveillance. 3rd ed. Oxford, England: Oxford University Press;
2010.
• Thacker SB, Birkhead GS. Surveillance. In: Gregg, MB, ed. Field epidemiology.
Oxford, England: Oxford University Press; 2008.
• Langmuir AD. The surveillance of communicable diseases of national
importance. New Engl J Med 1963;258:182–92.
• Foege WH, Hogan RC, Newton LH. Surveillance projects for selected diseases.
Int J Epidemiol 1976;5:29–37.
Resources and Additional Reading
51
• Centers for Disease Control and Prevention. Updated guidelines for evaluating
public health surveillance systems: recommendations from the Guidelines
Working Group. MMWR Recommend Rep 2001;50(No. RR-13).
• Centers for Disease Control and Prevention (CDC). Surveillance resource
center. Atlanta, GA: US Department of Health and Human Services, CDC; 2013.
http://www.cdc.gov/surveillancepractice/.
• Nash D, Mostashari F, Fine A, et al. Outbreak of West Nile virus infection in the
New York City area in 1999. N Engl J Med. 2001;344:1807–14.
• Török TJ, Tauxe RV, Wise RP, et al. A large community outbreak of salmonellosis
caused by intentional contamination of restaurant salad bars. JAMA
1997;278:389–95.
• Kim M, Berger D, Matte T. Diabetes in New York City: public health burden and
disparities. New York: New York City Department of Health and Mental
Hygiene; 2006.
http://www.nyc.gov/html/doh/downloads/pdf/epi/diabetes_chart_book.pdf.
• Swerdlow DL, Woodruff BA, Brady RC, et al. A waterborne outbreak in Missouri
of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann
Intern Med 1992;117:812–9.
Resources and Additional Reading
52
BONUS SLIDES
53
Link to Action
Provide data for programs, policies, and priorities
1994–95 1996–97
%Reportingdiabetes
Year
1998–99 2000–01 2002 2003 2004
Kim M, Berger D, Matte T. Diabetes in New York City: public health burden and disparities. New York: New York City Department of
Health and Mental Hygiene; 2006. http://www.nyc.gov/html/doh/downloads/pdf/epi/diabetes_chart_book.pdf. 54
Link to Action
Evaluate prevention and control effortsNo.ofcases
Swerdlow DL, Woodruff BA, Brady RC, et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody
diarrhea and death. Ann Intern Med 1992;117:812–9.
Water
system
flushed
Boil-water
order
Date of onset
55
Link to Action
Evaluate prevention and control efforts (continued)
No.ofcases
Swerdlow DL, Woodruff BA, Brady RC, et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody
diarrhea and death. Ann Intern Med 1992;117:812–9.
Water
system
flushed
Boil-water
order
Chlorine
added
Date of onset
56
Links provided in this course to nonfederal organizations are provided solely as a
service to our users. These links do not constitute an endorsement of these
organizations nor their programs by the Centers for Disease Control and
Prevention (CDC) or the federal government, and none should be inferred. CDC
is not responsible for the content contained at these sites.
Use of trade names and commercial sources is for identification only and does
not imply endorsement by the Division of Scientific Education and Professional
Development, Center for Surveillance, Epidemiology, and Laboratory Services,
Centers for Disease Control and Prevention, the Public Health Service, or the U.S.
Department of Health and Human Services.
The findings and conclusions in this course are those of the authors and do not
necessarily represent the official position of the Centers for Disease Control and
Prevention.
Disclaimers
57
For more information, please contact the Centers for Disease Control and Prevention
1600 Clifton Road NE, Atlanta, GA 30333
Telephone: 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348
Visit: http://www.cdc.gov | Contact CDC at: 1-800-CDC-INFO or http://www.cdc.gov/info
The findings and conclusions in this course are those of the authors and do not necessarily represent the official position of the
Centers for Disease Control and Prevention.
Center for Surveillance, Epidemiology, and Laboratory Services
Division of Scientific Education and Professional Development
‫المحاضر‬
‫البٌطار‬ ‫حاتم‬ ‫د‬
 ‫الصحٌة‬ ‫الرعاٌة‬ ‫ادارة‬ ‫استشاري‬
 ‫المستشفٌات‬ ‫ادارة‬ ً‫ف‬ ‫المصرٌة‬ ‫الزمالة‬ ‫زمٌل‬
‫العدوي‬ ‫ومكافحة‬
 ‫على‬ ‫حاصل‬‫دبلومة‬‫الطبٌة‬ ‫الجودة‬ ‫إلدارة‬ ‫هارفرد‬
 ‫عن‬ ‫ٌزٌد‬ ‫ما‬ ‫طبٌة‬ ‫اكادٌمٌات‬ ‫بعدة‬ ‫محاضر‬10
‫سنوات‬
 ‫محاضر‬ ‫بأكادٌمٌة‬ ‫الطبٌة‬ ‫الحقٌبة‬ifps
All copy rights © reserved to
Dr Hatem El Bitar

More Related Content

What's hot

Public Health Surveillance
Public Health SurveillancePublic Health Surveillance
Public Health Surveillance
uroosa farooq
 
Second PPS in the US. Shelly Magill (CDC)
Second PPS in the US. Shelly Magill (CDC)Second PPS in the US. Shelly Magill (CDC)
Second PPS in the US. Shelly Magill (CDC)
European Centre for Disease Prevention and Control (ECDC)
 
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
HopkinsCFAR
 
Surveillance
SurveillanceSurveillance
Surveillance
Akhilesh Bhargava
 
Surveilance
SurveilanceSurveilance
Surveilance
kwizera denis
 
EHR- 2016 Eeshika Mitra
EHR- 2016 Eeshika MitraEHR- 2016 Eeshika Mitra
EHR- 2016 Eeshika MitraEeshika Mitra
 
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
CrimsonpublishersCJMI
 
Vpd surveillance system
Vpd surveillance systemVpd surveillance system
Vpd surveillance system
Mohammad Ismail Zubair MD. MSc
 
Surveillance
SurveillanceSurveillance
Surveillance
anchal arora
 
critical review_RNTCP1 -
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -Isha Porwal
 
The Cochrane Library: Web 2.0 & phisical activity
The Cochrane Library:   Web 2.0 & phisical activity The Cochrane Library:   Web 2.0 & phisical activity
The Cochrane Library: Web 2.0 & phisical activity Giuseppe Fattori
 
Demographic surveillance
Demographic surveillanceDemographic surveillance
Demographic surveillance
SRM University, India
 
Measurement of outcome v5
Measurement  of outcome v5Measurement  of outcome v5
Measurement of outcome v5
aiswarya thomas
 
Survieellance by dr najeeb
Survieellance by dr najeebSurvieellance by dr najeeb
Survieellance by dr najeebmuhammed najeeb
 
SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT
SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT
SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT
IJDKP
 
Surveillance
SurveillanceSurveillance
Surveillance
Manisha Mandal
 
Vital Events Measurement in M&E
Vital Events Measurement in M&EVital Events Measurement in M&E
Vital Events Measurement in M&E
MEASURE Evaluation
 
Measuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of AfricaMeasuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of AfricaMEASURE Evaluation
 

What's hot (20)

Public Health Surveillance
Public Health SurveillancePublic Health Surveillance
Public Health Surveillance
 
Second PPS in the US. Shelly Magill (CDC)
Second PPS in the US. Shelly Magill (CDC)Second PPS in the US. Shelly Magill (CDC)
Second PPS in the US. Shelly Magill (CDC)
 
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
Ethical Considerations for a Public Health Response Using Molecular HIV Surve...
 
Surveillance
SurveillanceSurveillance
Surveillance
 
Surveilance
SurveilanceSurveilance
Surveilance
 
EHR- 2016 Eeshika Mitra
EHR- 2016 Eeshika MitraEHR- 2016 Eeshika Mitra
EHR- 2016 Eeshika Mitra
 
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
Comparison of Ultrabio HIV DNA PCR and Gag Real-Time PCR Assays for Total Hiv...
 
Health IT Project
Health IT Project Health IT Project
Health IT Project
 
Vpd surveillance system
Vpd surveillance systemVpd surveillance system
Vpd surveillance system
 
Surveillance
SurveillanceSurveillance
Surveillance
 
critical review_RNTCP1 -
critical review_RNTCP1 -critical review_RNTCP1 -
critical review_RNTCP1 -
 
The Cochrane Library: Web 2.0 & phisical activity
The Cochrane Library:   Web 2.0 & phisical activity The Cochrane Library:   Web 2.0 & phisical activity
The Cochrane Library: Web 2.0 & phisical activity
 
Demographic surveillance
Demographic surveillanceDemographic surveillance
Demographic surveillance
 
Measurement of outcome v5
Measurement  of outcome v5Measurement  of outcome v5
Measurement of outcome v5
 
Survieellance by dr najeeb
Survieellance by dr najeebSurvieellance by dr najeeb
Survieellance by dr najeeb
 
Ibrt07i2p79
Ibrt07i2p79Ibrt07i2p79
Ibrt07i2p79
 
SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT
SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT
SPATIAL CLUSTERING AND ANALYSIS ON HEPATITIS C VIRUS INFECTIONS IN EGYPT
 
Surveillance
SurveillanceSurveillance
Surveillance
 
Vital Events Measurement in M&E
Vital Events Measurement in M&EVital Events Measurement in M&E
Vital Events Measurement in M&E
 
Measuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of AfricaMeasuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of Africa
 

Similar to Introduction to-surveillance د حاتم البيطار

SURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENTSURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENT
Aneesa K Ayoob
 
Ch7 Public Health Surveillance.pptx
Ch7 Public Health Surveillance.pptxCh7 Public Health Surveillance.pptx
Ch7 Public Health Surveillance.pptx
Moseskiongo2
 
EPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENT
EPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENTEPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENT
EPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENT
edwinaron57
 
Chapter 18
Chapter 18Chapter 18
Chapter 18bodo-con
 
introduction-to-public-health. department of PHpdf
introduction-to-public-health. department of PHpdfintroduction-to-public-health. department of PHpdf
introduction-to-public-health. department of PHpdf
osmanolow
 
survalence.pptx
survalence.pptxsurvalence.pptx
survalence.pptx
MesfinShifara
 
Chapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docx
Chapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docxChapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docx
Chapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docx
zebadiahsummers
 
Applications on Public Health Surveillance
Applications on Public Health SurveillanceApplications on Public Health Surveillance
Applications on Public Health Surveillance
doniasadoun1
 
Week 10 Managing the Public Health Surveillance and.docx
Week 10 Managing the Public Health Surveillance and.docxWeek 10 Managing the Public Health Surveillance and.docx
Week 10 Managing the Public Health Surveillance and.docx
write5
 
Unit-IV Health Surveillance ANP m.sc I year.pptx
Unit-IV Health Surveillance ANP m.sc I year.pptxUnit-IV Health Surveillance ANP m.sc I year.pptx
Unit-IV Health Surveillance ANP m.sc I year.pptx
anjalatchi
 
Fundamental of epidemioloy
Fundamental of epidemioloyFundamental of epidemioloy
Fundamental of epidemioloy
Mahmoud Shaqria
 
DB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docxDB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docx
write22
 
DB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docxDB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docx
sdfghj21
 
Introduction to-epidemiology
Introduction to-epidemiologyIntroduction to-epidemiology
Introduction to-epidemiology
NatnaelMulushewa
 
introduction-to-epidemiology.pptx
introduction-to-epidemiology.pptxintroduction-to-epidemiology.pptx
introduction-to-epidemiology.pptx
anjalatchi
 
introduction-to-epidemiology.pptx
introduction-to-epidemiology.pptxintroduction-to-epidemiology.pptx
introduction-to-epidemiology.pptx
NicoleGentiles
 
introduction-to-epidemiology.pdf
introduction-to-epidemiology.pdfintroduction-to-epidemiology.pdf
introduction-to-epidemiology.pdf
jacob735118
 
Scholarly Project Presentation 6-21-15
Scholarly Project Presentation 6-21-15Scholarly Project Presentation 6-21-15
Scholarly Project Presentation 6-21-15Edward S. Gilman
 
7 community diagnosis
7 community diagnosis7 community diagnosis
7 community diagnosis
Anup Kharde
 
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
Xiaoming Zeng
 

Similar to Introduction to-surveillance د حاتم البيطار (20)

SURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENTSURVEILLANCE OF HEALTH EVENT
SURVEILLANCE OF HEALTH EVENT
 
Ch7 Public Health Surveillance.pptx
Ch7 Public Health Surveillance.pptxCh7 Public Health Surveillance.pptx
Ch7 Public Health Surveillance.pptx
 
EPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENT
EPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENTEPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENT
EPIDEMIOLOGY AND PUBLIC HEALTH IN HEALTH SYSTEM MANAGEMENT
 
Chapter 18
Chapter 18Chapter 18
Chapter 18
 
introduction-to-public-health. department of PHpdf
introduction-to-public-health. department of PHpdfintroduction-to-public-health. department of PHpdf
introduction-to-public-health. department of PHpdf
 
survalence.pptx
survalence.pptxsurvalence.pptx
survalence.pptx
 
Chapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docx
Chapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docxChapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docx
Chapter 19 Public Health InformaticsBrian Dixon PhDSaurabh .docx
 
Applications on Public Health Surveillance
Applications on Public Health SurveillanceApplications on Public Health Surveillance
Applications on Public Health Surveillance
 
Week 10 Managing the Public Health Surveillance and.docx
Week 10 Managing the Public Health Surveillance and.docxWeek 10 Managing the Public Health Surveillance and.docx
Week 10 Managing the Public Health Surveillance and.docx
 
Unit-IV Health Surveillance ANP m.sc I year.pptx
Unit-IV Health Surveillance ANP m.sc I year.pptxUnit-IV Health Surveillance ANP m.sc I year.pptx
Unit-IV Health Surveillance ANP m.sc I year.pptx
 
Fundamental of epidemioloy
Fundamental of epidemioloyFundamental of epidemioloy
Fundamental of epidemioloy
 
DB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docxDB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docx
 
DB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docxDB Question for Public Health in Disaster Management.docx
DB Question for Public Health in Disaster Management.docx
 
Introduction to-epidemiology
Introduction to-epidemiologyIntroduction to-epidemiology
Introduction to-epidemiology
 
introduction-to-epidemiology.pptx
introduction-to-epidemiology.pptxintroduction-to-epidemiology.pptx
introduction-to-epidemiology.pptx
 
introduction-to-epidemiology.pptx
introduction-to-epidemiology.pptxintroduction-to-epidemiology.pptx
introduction-to-epidemiology.pptx
 
introduction-to-epidemiology.pdf
introduction-to-epidemiology.pdfintroduction-to-epidemiology.pdf
introduction-to-epidemiology.pdf
 
Scholarly Project Presentation 6-21-15
Scholarly Project Presentation 6-21-15Scholarly Project Presentation 6-21-15
Scholarly Project Presentation 6-21-15
 
7 community diagnosis
7 community diagnosis7 community diagnosis
7 community diagnosis
 
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
 

More from د حاتم البيطار

supplementsinfo د حاتم البيطار زويل اكاديمي.pdf
supplementsinfo د حاتم البيطار زويل اكاديمي.pdfsupplementsinfo د حاتم البيطار زويل اكاديمي.pdf
supplementsinfo د حاتم البيطار زويل اكاديمي.pdf
د حاتم البيطار
 
nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...
nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...
nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...
د حاتم البيطار
 
بsupplementsinfo د حاتم البيطار زويل اكاديميب.pdf
بsupplementsinfo د حاتم البيطار زويل اكاديميب.pdfبsupplementsinfo د حاتم البيطار زويل اكاديميب.pdf
بsupplementsinfo د حاتم البيطار زويل اكاديميب.pdf
د حاتم البيطار
 
Dr Heba Shawqد حاتم البيطار زويل اكاديميi.pdf
Dr Heba Shawqد حاتم البيطار زويل اكاديميi.pdfDr Heba Shawqد حاتم البيطار زويل اكاديميi.pdf
Dr Heba Shawqد حاتم البيطار زويل اكاديميi.pdf
د حاتم البيطار
 
فورمة شغل حلوة zewail academy for more new slides press ctrl m.pptx
فورمة شغل حلوة zewail academy for more new slides press ctrl m.pptxفورمة شغل حلوة zewail academy for more new slides press ctrl m.pptx
فورمة شغل حلوة zewail academy for more new slides press ctrl m.pptx
د حاتم البيطار
 
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
د حاتم البيطار
 
Obesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
Obesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdfObesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
Obesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
د حاتم البيطار
 
final hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdffinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
د حاتم البيطار
 
Assi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdf
Assi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdfAssi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdf
Assi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdf
د حاتم البيطار
 
final hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdffinal hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdf
د حاتم البيطار
 
amera omran د حاتم البيطار اسينمنت القمة.pdf
amera omran د حاتم البيطار اسينمنت القمة.pdfamera omran د حاتم البيطار اسينمنت القمة.pdf
amera omran د حاتم البيطار اسينمنت القمة.pdf
د حاتم البيطار
 
asmaa qemaa turkey د حاتم البيطار اسينمنت القمة.pdf
asmaa  qemaa turkey د حاتم البيطار اسينمنت القمة.pdfasmaa  qemaa turkey د حاتم البيطار اسينمنت القمة.pdf
asmaa qemaa turkey د حاتم البيطار اسينمنت القمة.pdf
د حاتم البيطار
 
د حاتم البيطار كتب تغذية علاجية.pdf
د حاتم البيطار       كتب تغذية علاجية.pdfد حاتم البيطار       كتب تغذية علاجية.pdf
د حاتم البيطار كتب تغذية علاجية.pdf
د حاتم البيطار
 
د حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdf
د حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdfد حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdf
د حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdf
د حاتم البيطار
 
د حاتم البيطارالمنشطات والمكملات الغذائية.pdf
د حاتم البيطارالمنشطات والمكملات الغذائية.pdfد حاتم البيطارالمنشطات والمكملات الغذائية.pdf
د حاتم البيطارالمنشطات والمكملات الغذائية.pdf
د حاتم البيطار
 
سوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdf
سوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdfسوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdf
سوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdf
د حاتم البيطار
 
تغذية اطفالالتوحد د سوزان القمة د حاتم.pdf
تغذية اطفالالتوحد د سوزان القمة د حاتم.pdfتغذية اطفالالتوحد د سوزان القمة د حاتم.pdf
تغذية اطفالالتوحد د سوزان القمة د حاتم.pdf
د حاتم البيطار
 
د اسماء دويبي د حاتم البيطار تغذية قمة 1.pdf
د اسماء دويبي  د حاتم البيطار تغذية قمة 1.pdfد اسماء دويبي  د حاتم البيطار تغذية قمة 1.pdf
د اسماء دويبي د حاتم البيطار تغذية قمة 1.pdf
د حاتم البيطار
 
د اميرة عمران القمة د حاتم البيطار.pdf
د اميرة   عمران القمة د حاتم البيطار.pdfد اميرة   عمران القمة د حاتم البيطار.pdf
د اميرة عمران القمة د حاتم البيطار.pdf
د حاتم البيطار
 
د سوزان اسينمنت 3 القمة د حاتم البيطار.pdf
د سوزان اسينمنت 3 القمة د حاتم البيطار.pdfد سوزان اسينمنت 3 القمة د حاتم البيطار.pdf
د سوزان اسينمنت 3 القمة د حاتم البيطار.pdf
د حاتم البيطار
 

More from د حاتم البيطار (20)

supplementsinfo د حاتم البيطار زويل اكاديمي.pdf
supplementsinfo د حاتم البيطار زويل اكاديمي.pdfsupplementsinfo د حاتم البيطار زويل اكاديمي.pdf
supplementsinfo د حاتم البيطار زويل اكاديمي.pdf
 
nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...
nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...
nutrition_for_strengsupplementsinfo د حاتم البيطار زويل اكاديميزويل عربيth_an...
 
بsupplementsinfo د حاتم البيطار زويل اكاديميب.pdf
بsupplementsinfo د حاتم البيطار زويل اكاديميب.pdfبsupplementsinfo د حاتم البيطار زويل اكاديميب.pdf
بsupplementsinfo د حاتم البيطار زويل اكاديميب.pdf
 
Dr Heba Shawqد حاتم البيطار زويل اكاديميi.pdf
Dr Heba Shawqد حاتم البيطار زويل اكاديميi.pdfDr Heba Shawqد حاتم البيطار زويل اكاديميi.pdf
Dr Heba Shawqد حاتم البيطار زويل اكاديميi.pdf
 
فورمة شغل حلوة zewail academy for more new slides press ctrl m.pptx
فورمة شغل حلوة zewail academy for more new slides press ctrl m.pptxفورمة شغل حلوة zewail academy for more new slides press ctrl m.pptx
فورمة شغل حلوة zewail academy for more new slides press ctrl m.pptx
 
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...
 
Obesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
Obesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdfObesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
Obesityfinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
 
final hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdffinal hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028.pdf
 
Assi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdf
Assi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdfAssi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdf
Assi. 1 (lec1) H.Mزويل اكاديمي د حاتم البيطار.pdf
 
final hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdffinal hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdf
final hyper1د حاتم البيطار القمة اكاديمي 01202389028القيادة بالعربي.pdf
 
amera omran د حاتم البيطار اسينمنت القمة.pdf
amera omran د حاتم البيطار اسينمنت القمة.pdfamera omran د حاتم البيطار اسينمنت القمة.pdf
amera omran د حاتم البيطار اسينمنت القمة.pdf
 
asmaa qemaa turkey د حاتم البيطار اسينمنت القمة.pdf
asmaa  qemaa turkey د حاتم البيطار اسينمنت القمة.pdfasmaa  qemaa turkey د حاتم البيطار اسينمنت القمة.pdf
asmaa qemaa turkey د حاتم البيطار اسينمنت القمة.pdf
 
د حاتم البيطار كتب تغذية علاجية.pdf
د حاتم البيطار       كتب تغذية علاجية.pdfد حاتم البيطار       كتب تغذية علاجية.pdf
د حاتم البيطار كتب تغذية علاجية.pdf
 
د حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdf
د حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdfد حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdf
د حاتم البيطار بدائل السكريات الطبيعية ((السكريات الصناعية)).pdf
 
د حاتم البيطارالمنشطات والمكملات الغذائية.pdf
د حاتم البيطارالمنشطات والمكملات الغذائية.pdfد حاتم البيطارالمنشطات والمكملات الغذائية.pdf
د حاتم البيطارالمنشطات والمكملات الغذائية.pdf
 
سوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdf
سوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdfسوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdf
سوزان قمة تغذيةد حاتم البيطار القمة اسينمنت .pdf
 
تغذية اطفالالتوحد د سوزان القمة د حاتم.pdf
تغذية اطفالالتوحد د سوزان القمة د حاتم.pdfتغذية اطفالالتوحد د سوزان القمة د حاتم.pdf
تغذية اطفالالتوحد د سوزان القمة د حاتم.pdf
 
د اسماء دويبي د حاتم البيطار تغذية قمة 1.pdf
د اسماء دويبي  د حاتم البيطار تغذية قمة 1.pdfد اسماء دويبي  د حاتم البيطار تغذية قمة 1.pdf
د اسماء دويبي د حاتم البيطار تغذية قمة 1.pdf
 
د اميرة عمران القمة د حاتم البيطار.pdf
د اميرة   عمران القمة د حاتم البيطار.pdfد اميرة   عمران القمة د حاتم البيطار.pdf
د اميرة عمران القمة د حاتم البيطار.pdf
 
د سوزان اسينمنت 3 القمة د حاتم البيطار.pdf
د سوزان اسينمنت 3 القمة د حاتم البيطار.pdfد سوزان اسينمنت 3 القمة د حاتم البيطار.pdf
د سوزان اسينمنت 3 القمة د حاتم البيطار.pdf
 

Recently uploaded

PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx Program
 
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
salisonsalim1
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
nktiacc3
 
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhfOne Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
AbdulMunim54
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
Kenneth Kruk
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
Rajarambapu College of Pharmacy Kasegaon Dist Sangli
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...
Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...
Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...
IMARC Group
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
Iris Thiele Isip-Tan
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
NX Healthcare
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
khvdq584
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 

Recently uploaded (20)

PrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic IllnessesPrudentRx's Function in the Management of Chronic Illnesses
PrudentRx's Function in the Management of Chronic Illnesses
 
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
Mastoid cavity problem and obilteration presentation by Dr Salison Salim Pani...
 
NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022NKTI Annual Report - Annual Report FY 2022
NKTI Annual Report - Annual Report FY 2022
 
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhfOne Gene One Enzyme Theory.pptxvhvhfhfhfhf
One Gene One Enzyme Theory.pptxvhvhfhfhfhf
 
Under Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's StrategyUnder Pressure : Kenneth Kruk's Strategy
Under Pressure : Kenneth Kruk's Strategy
 
Rate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdfRate Controlled Drug Delivery Systems.pdf
Rate Controlled Drug Delivery Systems.pdf
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...
Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...
Radiation Oncology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis an...
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
Artificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular TherapyArtificial Intelligence to Optimize Cardiovascular Therapy
Artificial Intelligence to Optimize Cardiovascular Therapy
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
KEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docxKEY Points of Leicester travel clinic In London doc.docx
KEY Points of Leicester travel clinic In London doc.docx
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
定制(wsu毕业证书)美国华盛顿州立大学毕业证学位证书实拍图原版一模一样
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 

Introduction to-surveillance د حاتم البيطار

  • 1. Public Health 101 Series Instructor name Title Organization Introduction to Public Health Surveillance Center for Surveillance, Epidemiology, and Laboratory Services Division of Scientific Education and Professional Development Note: This slide set is in the public domain and may be customized as needed by the user for informational or educational purposes. Permission from the Centers for Disease Control and Prevention is not required, but citation of the source is appreciated.
  • 2. Course Topics 2 Introduction to Public Health Surveillance 1. A Public Health Approach 2. What is Public Health Surveillance? 3. Public Health Surveillance Role and Uses 4. Public Health Surveillance Legal Basis 5. Public Health Surveillance Types and Attributes 6. Public Health Surveillance Process
  • 3. By the end of this session, you will be able to • define public health surveillance • describe the goal of public health surveillance • describe the uses of a public health surveillance system • recognize the legal basis for public health surveillance in the United States • compare active and passive public health surveillance • identify sources of data commonly used for public health surveillance • describe the public health surveillance process Learning Objectives 3
  • 4. A Public Health Approach Topic 1 4
  • 5. A Public Health Approach Surveillance Risk Factor Identification Intervention Evaluation Implementation 5
  • 6. Public Health Core Sciences 6
  • 7. Topic 2 What is Public Health Surveillance? 7
  • 8. The ongoing, systematic collection, analysis, and interpretation of health-related data essential to planning, implementation, and evaluation of public health practice, closely integrated with the timely dissemination of these data to those responsible for prevention and control Public Health Surveillance Defined Adapted from: Thacker SB, Birkhead GS. Surveillance. In: Gregg, MB, ed. Field epidemiology. Oxford, England: Oxford University Press; 2008. 8
  • 10. Goal of Public Health Surveillance Provide information that can be used for health action by public health personnel, government leaders, and the public to guide public health policy and programs Smith PF, Hadler JL, Stanbury M, et al. Blueprint version 2.0: updating public health surveillance for the 21st century. J Public Health Manag Pract 2013;19:231–9. 10
  • 11. A. systemic, short-term B. ongoing, systemic C. ongoing, systematic D. methodical, ongoing Public Health Surveillance is the ________, __________ collection, analysis, and interpretation of health- related data. Knowledge Check 11
  • 12. What is the goal of public health surveillance? Knowledge Check 12 A. To give public health personnel policies to regulate B. To provide information to be used for public health action C. To guide Congress in enacting public health laws D. To keep the public aware of new diseases
  • 13. Topic 3 Public Health Surveillance Role and Uses 13
  • 14. • Identify patients and their contacts for treatment and intervention • Detect epidemics, health problems, changes in health behaviors • Estimate magnitude and scope of health problems • Measure trends and characterize disease • Monitor changes in infectious and environmental agents • Assess effectiveness of programs and control measures • Develop hypotheses and stimulate research Uses of Public Health Surveillance 14
  • 15. Whooping Cough Kills Five in California; State Declares an Epidemic Number of Rare E. Coli Cases In U.S. Rose Last Year Increase Seen in Deaths from Pneumonia and Flu Percentage of New Yorkers Lighting Up is Down to 14% New CDC Report Shows Adult Obesity Growing or Holding Steady in All States 15 Public Health Headlines
  • 16. Number of Rare E. Coli Cases In U.S. Rose Last Year 16 Neuman W. Number of Rare E. Coli Cases In U.S. Rose Last Year. The New York Times. June 7, 2011. http://www.nytimes.com. Accessed July 8, 2014.
  • 17. Identify the surveillance uses that can be linked to the New York Times E. coli article. A. Measure trends of a particular disease B. Estimate the magnitude of the problem C. Monitor changes in infectious and environmental agents D. Assess effectiveness of programs and control measures E. All of the above Knowledge Check 17
  • 18. Topic 4 Public Health Surveillance Legal Basis 18
  • 19. States have authority based on the U.S. Constitution • General welfare clause • Interstate commerce clause CDC responds when • disease or condition has interstate implications • invited by a state Legal Authority for Conducting Public Health Surveillance 19
  • 20. State-Based Notifiable Disease Surveillance Systems • Mandated by state law or regulation • Health care providers, hospitals, and laboratories are required to report cases to the local health department (LHD) • The LHD is usually responsible for case investigation and action • The LHD forwards the disease report to the state health department • The state health department assists the LHD as needed 20
  • 21. The purpose and legal basis for public health surveillance is granted by which U.S. document? A. Bill of Rights B. Declaration of Independence C. U.S. Constitution D. 1812 Treaty of Public Health Knowledge Check 21
  • 22. CDC must be invited by a state before conducting public health surveillance. A. True B. False Knowledge Check 22
  • 23. Topic 5 Public Health Surveillance Types and Attributes 23
  • 24. Passive Surveillance Active Surveillance • Diseases are reported by health care providers • Simple and inexpensive • Limited by incompleteness of reporting and variability of quality • Health agencies contact health providers seeking reports • Ensures more complete reporting of conditions • Used in conjunction with specific epidemiologic investigation Types of Public Health Surveillance 24
  • 25. Reporting of health events by health professionals who are selected to represent a geographic area or a specific reporting group Can be active or passive Sentinel Surveillance Focuses on one or more symptoms rather than a physician-diagnosed or laboratory-confirmed disease Syndromic Surveillance Other Types of Public Health Surveillance 25
  • 26. Surveillance System Attributes 26 Attribute Question It Answers Usefulness How useful is the system in accomplishing its objectives? Data quality How reliable are the available data? How complete and accurate are data fields in the reports received by the system? Timeliness How quickly are reports received? Flexibility How quickly can the system adapt to changes? Simplicity How easy is the system’s operation?
  • 27. Surveillance System Attributes 27 Attribute Question It Answers Stability Does the surveillance system work well? Does it break down often? Sensitivity How well does it capture the intended cases? Predictive value positive How many of the reported cases meet the case definition? Representativeness How good is the system at representing the population under surveillance? Acceptability How easy is the system’s operation?
  • 28. Knowledge Check The New York State Department of Health contacts the health providers in District A every Friday to obtain the number of patients examined with Influenza. What type of surveillance is this? A. Passive B. Active 28
  • 29. Topic 6 29 Public Health Surveillance Process
  • 30. Before collecting data, decide on the overarching goal of the system Surveillance Process Data Collection Data Analysis Data Interpretation Data Dissemination Link to Action 30
  • 31. Data Sources for Public Health Surveillance • Reported diseases or syndromes • Electronic health records (e.g., hospital discharge data) • Vital records (e.g., birth and death certificates) • Registries (e.g., cancer, immunization) • Surveys (e.g., National Health and Nutrition Examination Survey [NHANES]) 31
  • 32. Nationally Notifiable Disease Surveillance System (NNDSS) Many diseases on a state list are also nationally notifiable 32
  • 33. Reporting to WHO is required for cases of Internationally Notifiable Diseases 33 • Smallpox • Poliomyelitis (wild type) • Human influenza caused by any new subtype • Severe acute respiratory syndrome (SARS)
  • 34. • Who will analyze the data? • What methodology will they use? • How often will they analyze the data? Surveillance Data Analysis Data Collection Data Analysis Data Interpretation Data Dissemination Link to Action 34
  • 35. Patients Hospitalized with West Nile Virus Infection, by Week, New York, 1999 Week of illness onset Nash D, Mostashari F, Fine A, et al. Outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807–14. 35
  • 36. North Queens Serosurvey Area Surveillance Data Analysis by Place Laboratory-Confirmed WNV Human Cases — August–September 1999 Map Courtesy of the New York City Department of Health and Mental Hygiene 36
  • 37. Characteristic No. of Patients (%) Population at Risk Rate of Infection per Million Population Age (years) 0–19 2 (3) 2,324,081 0.9 20–29 1 (2) 1,553,981 0.6 30–39 3 (5) 1,549,111 1.9 40–49 1 (2) 1,177,190 0.8 50–59 9 (15) 867,331 10.4 60–69 12 (22) 814,838 16.0 70–79 18 (31) 534,785 33.7 ≥80 12 (20) 281,054 42.7 Age category (years) ≥50 52 (88) 2,498,008 20.8 <50 7 (12) 6,604,363 1.1 Sex Male 31 (53) 4,289,988 7.2 Female 28 (47) 4,812,383 5.8 Race White 41 (69) 5,983,901 6.9 Nonwhite 9 (15) 3,118,470 2.9 Unknown 9 (15) -- -- Borough or county of residence New York City Brooklyn (Kings) 3 (5) 2,300,664 1.3 Bronx 9 (15) 1,203,789 7.5 Manhattan 1 (2) 1,487,536 0.7 Queens 32 (54) 1,951,599 16.4 Staten Island (Richmond) 0 379,999 0.0 New York State Nassau 6 (10) 1,287,348 4.7 Westchester 8 (14) 847,866 9.1 Data Analysis by Person Do you notice any patterns in the rates? 37Nash D, Mostashari F, Fine A, et al. Outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807–14. Demographics for Persons Hospitalized for WNV and Population Rates of Infection
  • 38. Data interpretation is closely coupled with data analysis Surveillance Data Interpretation Data Collection Data Analysis Data Interpretation Data Dissemination Link to Action 38
  • 39. What Can Account for an Apparent Increase in Cases?Number of Rare E. Coli Cases In U.S. Rose Last Year 39 Neuman, W. Rare E. Coli Cases Rose In the U.S. Last Year. New York Times June 7, 2011. http://www.nytimes.com. Accessed July 9, 2014.
  • 40. • Health agency newsletters, bulletins, or alerts • Surveillance summaries and reports • Medical and epidemiologic journal articles • Press releases and social media Data Dissemination Data Collection Data Analysis Data Interpretation Data Dissemination Link to Action 40
  • 41. • Public health practitioners • Clinicians and other health care providers • Policy and other decision makers • Community organizations • The general public Data Dissemination Target Audiences 41
  • 42. Public health surveillance should always have a link to action Surveillance Link to Action Data Collection Data Analysis Data Interpretation Data Dissemination Link to Action 42
  • 43. Link to Action Monitor trends and patterns in disease, risk factors, and agents 43 Source: Centers for Disease Control and Prevention (CDC). National Notifiable Diseases Surveillance System and Supplemental Pertussis Surveillance System and 1922-1949, passive reports to the US Public Health Service. Atlanta, GA: US Department of Health and Human Services, CDC. Available at: http://www.cdc.gov/pertussis/images/incidence-graph.jpg. Pertussis (Whooping Cough) Cases, by Year — United States, 1922–2000
  • 44. Choose the option that is NOT a part of the public health surveillance process. A. Data dissemination B. Data storage C. Link to action D. Data collection Knowledge Check 44
  • 45. In data interpretation, by identifying the ___________, ________, and _____________, you can more easily determine how and why the health event occurred. A. disease, risk, occurrence B. person, protocol, risk C. person, place, time D. risk, protocol, disease Knowledge Check 45
  • 46. Choose the option that is NOT a source of data used for public health surveillance. A. Administrative data systems B. Vital records C. Newspaper articles D. Disease notifications Knowledge Check 46
  • 47. • Describe the burden of or potential for disease • Monitor trends and patterns in disease, risk factors, and agents • Detect sudden changes in disease occurrence and distribution • Provide data for programs, policies, and priorities • Evaluate prevention and control efforts Public Health Surveillance-Based Action 47
  • 48. Foege WH, Hogan RC, Newton LH. Surveillance projects for selected diseases. Int J Epidemiol 1976;5:29–37. 48 Photo: Kay Hinton, Emory University “The reason for collecting, analyzing, and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow.” —William Foege, 1976
  • 49. During this session, you learned to • define public health surveillance • describe the goal of public health surveillance • describe the uses of public health surveillance system • recognize the legal basis for public health surveillance in the United States • compare active and passive public health surveillance • identify sources of data commonly used for public health surveillance • describe the public health surveillance process Course Summary 49
  • 51. • Smith PF, Hadler JL, Stanbury M, et al. Blueprint version 2.0: updating public health surveillance for the 21st century. J Public Health Manag Pract 2013;19:231–9. • Centers for Disease Control and Prevention. CDC’s vision for public health surveillance in the 21st century. Morb Mortal Wkly Rep 2012;61(Suppl, July 27, 2012):1–40. • Centers for Disease Control and Prevention (CDC). Principles of epidemiology in public health practice [Self-Study Course]. 3rd ed. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. http://www.cdc.gov/osels/scientific_edu/ss1978/SS1978.pdf. • Lee LM, Teutsch SM, Thacker SB, St. Louis M, Eds. Principles and practice of public health surveillance. 3rd ed. Oxford, England: Oxford University Press; 2010. • Thacker SB, Birkhead GS. Surveillance. In: Gregg, MB, ed. Field epidemiology. Oxford, England: Oxford University Press; 2008. • Langmuir AD. The surveillance of communicable diseases of national importance. New Engl J Med 1963;258:182–92. • Foege WH, Hogan RC, Newton LH. Surveillance projects for selected diseases. Int J Epidemiol 1976;5:29–37. Resources and Additional Reading 51
  • 52. • Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recommend Rep 2001;50(No. RR-13). • Centers for Disease Control and Prevention (CDC). Surveillance resource center. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. http://www.cdc.gov/surveillancepractice/. • Nash D, Mostashari F, Fine A, et al. Outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807–14. • Török TJ, Tauxe RV, Wise RP, et al. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA 1997;278:389–95. • Kim M, Berger D, Matte T. Diabetes in New York City: public health burden and disparities. New York: New York City Department of Health and Mental Hygiene; 2006. http://www.nyc.gov/html/doh/downloads/pdf/epi/diabetes_chart_book.pdf. • Swerdlow DL, Woodruff BA, Brady RC, et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med 1992;117:812–9. Resources and Additional Reading 52
  • 54. Link to Action Provide data for programs, policies, and priorities 1994–95 1996–97 %Reportingdiabetes Year 1998–99 2000–01 2002 2003 2004 Kim M, Berger D, Matte T. Diabetes in New York City: public health burden and disparities. New York: New York City Department of Health and Mental Hygiene; 2006. http://www.nyc.gov/html/doh/downloads/pdf/epi/diabetes_chart_book.pdf. 54
  • 55. Link to Action Evaluate prevention and control effortsNo.ofcases Swerdlow DL, Woodruff BA, Brady RC, et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med 1992;117:812–9. Water system flushed Boil-water order Date of onset 55
  • 56. Link to Action Evaluate prevention and control efforts (continued) No.ofcases Swerdlow DL, Woodruff BA, Brady RC, et al. A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med 1992;117:812–9. Water system flushed Boil-water order Chlorine added Date of onset 56
  • 57. Links provided in this course to nonfederal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations nor their programs by the Centers for Disease Control and Prevention (CDC) or the federal government, and none should be inferred. CDC is not responsible for the content contained at these sites. Use of trade names and commercial sources is for identification only and does not imply endorsement by the Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, the Public Health Service, or the U.S. Department of Health and Human Services. The findings and conclusions in this course are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Disclaimers 57
  • 58. For more information, please contact the Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA 30333 Telephone: 1-800-CDC-INFO (232-4636)/TTY: 1-888-232-6348 Visit: http://www.cdc.gov | Contact CDC at: 1-800-CDC-INFO or http://www.cdc.gov/info The findings and conclusions in this course are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Center for Surveillance, Epidemiology, and Laboratory Services Division of Scientific Education and Professional Development
  • 59. ‫المحاضر‬ ‫البٌطار‬ ‫حاتم‬ ‫د‬  ‫الصحٌة‬ ‫الرعاٌة‬ ‫ادارة‬ ‫استشاري‬  ‫المستشفٌات‬ ‫ادارة‬ ً‫ف‬ ‫المصرٌة‬ ‫الزمالة‬ ‫زمٌل‬ ‫العدوي‬ ‫ومكافحة‬  ‫على‬ ‫حاصل‬‫دبلومة‬‫الطبٌة‬ ‫الجودة‬ ‫إلدارة‬ ‫هارفرد‬  ‫عن‬ ‫ٌزٌد‬ ‫ما‬ ‫طبٌة‬ ‫اكادٌمٌات‬ ‫بعدة‬ ‫محاضر‬10 ‫سنوات‬  ‫محاضر‬ ‫بأكادٌمٌة‬ ‫الطبٌة‬ ‫الحقٌبة‬ifps
  • 60. All copy rights © reserved to Dr Hatem El Bitar